date/time interval
- July 1, 2016 - June 30, 2022
Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 2698930